ArticleChina CDC weekly2026
Carotid Atherosclerosis and Metabolic Characteristics Among High-Risk Cardiovascular Populations of Four Ethnic Groups - Yunnan Province, China, 2024.
Article in China CDC weekly, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: This study explored the distribution of carotid atherosclerosis (CAS) in high-risk individuals with cardiovascular disease (CVD) across four ethnic groups: the Han, Yi, Dai, and Lisu. Methods: The China-PAR model was used to estimate 10-year CVD risk. Participants with a 10-year risk score of 10% or higher underwent carotid ultrasonography, biochemical tests for blood glucose, lipids, homocysteine, and a standardized physical examination. Results: The Han had the lowest remnant cholesterol (Remnant-C) levels but the highest atherogenic index of plasma (AIP), triglyceride-glucose (TyG), and lipid accumulation product (LAP) levels. The Dai had the highest prevalence of hypertension, diabetes, hyperhomocysteinemia (HHcy), and Remnant-C. The Lisu had the lowest prevalence of diabetes and HHcy but the highest rates of obesity, central obesity, and dyslipidemia. Yi had the lowest burden of overweight, obesity, dyslipidemia, and the continuous metabolic syndrome score (cMetS), AIP, TyG, and LAP.Carotid intima-media thickness (cIMT) differed minimally among ethnic groups (range: 0.81-0.85 mm). The Dai had the lowest prevalence of carotid plaque (CP) 15.27% (341/2,233), yet the highest prevalence of carotid stenosis (CS) 46.22% (1,032/2,233). In contrast, Lisu had the highest prevalence of CP 57.29% (495/864) and the lowest prevalence of CS 3.13% (27/864). The Han population had the highest prevalence of multiple CP 31.82% (6,081/19,109) and CAS 74.79% (14,291/19,019), while the Yi population had the lowest prevalence 70.53% (3,453/4,896). Conclusion: The marked ethnic differences in CAS and metabolic status should be taken into account in future CVD prevention and control strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.